Corticosteroid-induced myopathy mimicking therapy-resistant asthma

Annals of Allergy, Asthma and Immunology

Volumn 99, Issue 4, 2007, Pages 371-374

  Yamaguchi, Masafumi ^a   Niimi, Akio ^a   Minakuchi, Masayoshi ^b   Matsumoto, Hisako ^a   Shimizu, Koichi ^c   Chin, Kazuo ^a   Mishima, Michiaki ^a  

^a KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b TENRI HOSPITAL   (Japan)

^c Showa General Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIASTHMATIC AGENT; BETAMETHASONE; CORTICOSTEROID; FLUTICASONE PROPIONATE; HYDROCORTISONE SODIUM SUCCINATE; METHYLPREDNISOLONE SODIUM SUCCINATE; NONSTEROID ANTIINFLAMMATORY AGENT; PRANLUKAST; PREDNISOLONE; PREDNISOLONE HEMISUCCINATE; SALBUTAMOL; THEOPHYLLINE; TULOBUTEROL;

ADULT; AIRFLOW; ARTICLE; ASTHMA; CASE REPORT; DISEASE EXACERBATION; DISEASE SEVERITY; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; ELECTROMYOGRAPHY; FATALITY; FEMALE; HOSPITAL ADMISSION; HUMAN; INHALER; JAPAN; LONG TERM CARE; LUNG FUNCTION; MYOPATHY; PRIORITY JOURNAL; RECURRENT DISEASE; SYSTEMIC THERAPY; WHEEZING;

EID: 35349020374     PISSN: 10811206     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1081-1206(10)60556-X     Document Type: Article

References (15)

1. MacFarlane IA, Rosenthal FD. Severe myopathy after status asthmaticus. Lancet. 1977;2:615.
2. Shee CD. Risk factors of hydrocortisone myopathy in acute severe asthma. Respir Med. 1990;84:229-233.
3. Lacomis D, Smith TW, Chad DA. Acute myopathy and neuropathy in status asthmaticus: case report and literature review. Muscle Nerve. 1993;16:91-98.
4. Behbehani NA, Al-Mane F, D'yachkova Y, et al. Myopathy following mechanical ventilation for acute severe asthma. Chest. 1999;115:1627-1631.
5. Knox AJ, Mascie-Taylor BH, Muers MF. Acute hydrocortisone myopathy in acute severe asthma. Thorax. 1986;41:411-412.
6. Polsonetti BW, Joy SD, Laos LF. Steroid-induced myopathy in the ICU. Ann Pharmacother. 2002;36:1741-1744.
7. Mitsui T, Umaki Y, Nagasawa M, Akaike M, Ohtsuka S, Odomi M, Aki K, Matsumoto T. Motor neuron involvement in a patient with long-term corticosteroid administration. Intern Med. 2003;42:862-866.
8. Kume H, Kondo M, Ito Y, Suzuki R, Yamaki K, Takagi K. Effects of sustained-release tulobuterol on asthma control and beta-adrenoceptor function. Clin Exp Pharmacol Physiol. 2002;29:1076-1083.
9. Fukuchi Y, Nagai A, Seyama K, et al. Clinical efficacy and safety of transdermal tulobuterol in the treatment of stable COPD: an open-label comparison with inhaled salmeterol. Treat Respir Med. 2005;4:447-455.
10. Mendelson LM, Meltzer EO, Hamburger RN. Anaphylaxis-like reactions to corticosteroid therapy. J Allergy Clin Immunol. 1974;54:125-131.
11. Nakamura H, Matsuse H, Obase Y, et al. Clinical evaluation of anaphylactic reactions to intravenous corticosteroids in adult asthmatics. Respiration. 2002;69:309-313.
12. Thomas PK. Myopathy. BMJ. 1970;1:413-415.
13. Chung KF, Godard P, Adelroth E, et al. Difficult/therapy-resistant asthma: the need for an integrated approach to define clinical phenotypes, evaluate risk factors, understand pathophysiology and find novel therapies. ERS Task Force on Difficult/Therapy-Resistant Asthma. European Respiratory Society. Eur Respir J. 1999;13:1198-1208.
14. Wenzel SE, Fahy JV, Irvin CG, et al. Proceedings of the ATS workshop on refractory asthma: current understanding, recommendations, and unanswered questions. Am J Respir Crit Care Med. 2000;162:2341-2351.
15. Thomas P, Geddes DM, Barnes PJ. Pseudo-steroid resistant asthma. Thorax. 1999;54:352-356.